{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:07:03Z","timestamp":1788671223425,"version":"build-2803163510"},"reference-count":93,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2019,8,11]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aims of this study were to update the evidence on the incidence and prevalence rates of vaccine preventable infections (VPI) in patients with autoimmune inflammatory rheumatic diseases (AIIRD) and compare the data to the general population when available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A literature search was performed using Medline, Embase and Cochrane library (October 2009 to August 2018). The primary outcome was the incidence or prevalence of VPI in the adult AIIRD population. Meta-analysis was performed when appropriate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sixty-three publications out of 3876 identified records met the inclusion criteria: influenza (n=4), pneumococcal disease (n=7), hepatitis B (n=10), herpes zoster (HZ) (n=29), human papillomavirus (HPV) infection (n=13). An increased incidence of influenza and pneumococcal disease was reported in patients with AIIRD. HZ infection-pooled incidence rate ratio (IRR) was 2.9 (95% CI 2.4 to 3.3) in patients with AIIRD versus general population. Among AIIRD, inflammatory myositis conferred the highest incidence rate (IR) of HZ (pooled IRR 5.1, 95% CI 4.3 to 5.9), followed by systemic lupus erythematosus (SLE) (pooled IRR 4.0, 95% CI 2.3 to 5.7) and rheumatoid arthritis (pooled IRR 2.3, 95% CI 2.1 to 2.6). HPV infection-pooled prevalence ratio was 1.6, 95% CI 0.7 to 3.4 versus general population, based on studies mainly conducted in the SLE population in Latin America and Asia. Pooled prevalence of hepatitis B surface antigen and hepatitis B core antibody in patients with AIIRD was similar to the general population, 3%, 95% CI 1% to 5% and 15%, 95% CI 7% to 26%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Current evidence shows an increased risk of VPI in patients with AIIRD, emphasising that prevention of infections is essential in these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2019-001041","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:35:14Z","timestamp":1568910914000},"page":"e001041","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":138,"title":["Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-4207","authenticated-orcid":false,"given":"Victoria","family":"Furer","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4558-1270","authenticated-orcid":false,"given":"Christien","family":"Rondaan","sequence":"additional","affiliation":[{"name":"Medical Microbiology and Infection Prevention, UMCG, Groningen, The Netherlands"},{"name":"Rheumatology and Clinical Immunology, UMCG, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Heijstek","sequence":"additional","affiliation":[{"name":"Internal Medicine and Allergology, Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"van Assen","sequence":"additional","affiliation":[{"name":"Internal Medicine (Infectious Diseases), Treant Care Group, Hoogeveen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bijl","sequence":"additional","affiliation":[{"name":"Internal Medicine, Martini Hospital, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-3677","authenticated-orcid":false,"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand C","family":"Breedveld","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"D'Amelio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza University of Rome, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Cochin, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7853-514X","authenticated-orcid":false,"given":"Meliha Crnkic","family":"Kapetanovic","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Section for Rheumatology, Lund University and Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-5785","authenticated-orcid":false,"given":"Jacob M","family":"van Laar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-4328","authenticated-orcid":false,"given":"Annette","family":"Ladefoged de Thurah","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Section of Rheumatology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-6620","authenticated-orcid":false,"given":"Robert","family":"Landew\u00e9","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Cochin, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Justus-Liebig-University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, King Christian X's Hospital for Rheumatic Diseases, Graasten, Denmark"},{"name":"Department of Thrombosis and Haemophilia, Guy's and St Thomas' Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Smolar","sequence":"additional","affiliation":[{"name":"Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Walker","sequence":"additional","affiliation":[{"name":"Elgin, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[{"name":"Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, University Medical Center Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-3639","authenticated-orcid":false,"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"2025090312575769000_5.2.e001041.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137216"},{"key":"2025090312575769000_5.2.e001041.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0441-9"},{"key":"2025090312575769000_5.2.e001041.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.12.003"},{"key":"2025090312575769000_5.2.e001041.4","doi-asserted-by":"crossref","unstructured":"Rondaan C , Furer V , Heijstek MW , et al . Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open 2019.","DOI":"10.1136\/rmdopen-2019-001035"},{"key":"2025090312575769000_5.2.e001041.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26387"},{"key":"2025090312575769000_5.2.e001041.6","unstructured":"Wells G , Shea B , O'Connell D . The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http:\/\/wwwohrica\/programs\/clinical_epidemiology\/oxfordasp"},{"key":"2025090312575769000_5.2.e001041.7","unstructured":"Oxford centre for evidence-based medicine \u2013 levels of evidence. The Oxford 2009 level of evidence updated in, 2012"},{"key":"2025090312575769000_5.2.e001041.8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys Ther"},{"key":"2025090312575769000_5.2.e001041.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.063"},{"key":"2025090312575769000_5.2.e001041.10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-13-158","article-title":"Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study","volume":"13","author":"Blumentals","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"2025090312575769000_5.2.e001041.11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/03009742.2012.670729","article-title":"Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis","volume":"41","author":"Dirven","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"2025090312575769000_5.2.e001041.12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4081\/reumatismo.2012.299","article-title":"Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents","volume":"64","author":"Bello","year":"2012","journal-title":"Reumatismo"},{"key":"2025090312575769000_5.2.e001041.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160909"},{"key":"2025090312575769000_5.2.e001041.14","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.4.586"},{"key":"2025090312575769000_5.2.e001041.15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.13.1393"},{"key":"2025090312575769000_5.2.e001041.16","unstructured":"Pneumococcal disease surveillance and reporting. centers for disease control and prevention (CDC). Available: https:\/\/wwwcdcgov\/pneumococcal\/surveillancehtml [Accessed 1 Aug 2018]."},{"key":"2025090312575769000_5.2.e001041.17","doi-asserted-by":"crossref","unstructured":"Shea KM , Edelsberg J , Weycker D , et al . Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014;1.doi:10.1093\/ofid\/ofu024","DOI":"10.1093\/ofid\/ofu024"},{"key":"2025090312575769000_5.2.e001041.18","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2011-200168"},{"key":"2025090312575769000_5.2.e001041.19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ803"},{"key":"2025090312575769000_5.2.e001041.20","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314543918"},{"key":"2025090312575769000_5.2.e001041.21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jbspin.2017.05.012","article-title":"Pneumococcal infection in patients with systemic lupus erythematosus","volume":"85","author":"Schurder","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2025090312575769000_5.2.e001041.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-016-1432-4","article-title":"Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions","volume":"16","author":"Weycker","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2025090312575769000_5.2.e001041.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1648-2","article-title":"Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors","volume":"16","author":"Backhaus","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025090312575769000_5.2.e001041.24","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615599151"},{"key":"2025090312575769000_5.2.e001041.25","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21928"},{"key":"2025090312575769000_5.2.e001041.26","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21812"},{"key":"2025090312575769000_5.2.e001041.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201108"},{"key":"2025090312575769000_5.2.e001041.28","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-013-0550-8"},{"key":"2025090312575769000_5.2.e001041.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1099"},{"key":"2025090312575769000_5.2.e001041.30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/14397595.2014.984829","article-title":"Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010","volume":"25","author":"Nakajima","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2025090312575769000_5.2.e001041.31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/imj.12679","article-title":"Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-\u03b1 inhibitors","volume":"45","author":"Segan","year":"2015","journal-title":"Intern Med J"},{"key":"2025090312575769000_5.2.e001041.32","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22628"},{"key":"2025090312575769000_5.2.e001041.33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/acr.22470","article-title":"Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy","volume":"67","author":"Yun","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2025090312575769000_5.2.e001041.34","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025090312575769000_5.2.e001041.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209131"},{"key":"2025090312575769000_5.2.e001041.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209322"},{"key":"2025090312575769000_5.2.e001041.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161196"},{"key":"2025090312575769000_5.2.e001041.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210457"},{"key":"2025090312575769000_5.2.e001041.39","doi-asserted-by":"crossref","unstructured":"Liao Tsai\u2010Ling , Lin Ching\u2010Heng , Chen Hsin\u2010Hua , et al . Significant associations of neurological complications of herpes zoster with stroke in rheumatoid arthritis patients. J Am Heart Assoc 2017;6.doi:10.1161\/JAHA.117.006304","DOI":"10.1161\/JAHA.117.006304"},{"key":"2025090312575769000_5.2.e001041.40","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/1756-185X.13300","article-title":"No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database","volume":"21","author":"Sakai","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2025090312575769000_5.2.e001041.41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205148"},{"key":"2025090312575769000_5.2.e001041.42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/14397595.2017.1325034","article-title":"The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database","volume":"28","author":"Lim","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2025090312575769000_5.2.e001041.43","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181d52ed7"},{"key":"2025090312575769000_5.2.e001041.44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1590\/S1807-59322011000700009","article-title":"Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort","volume":"66","author":"Chen","year":"2011","journal-title":"Clinics"},{"key":"2025090312575769000_5.2.e001041.45","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312470186"},{"key":"2025090312575769000_5.2.e001041.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134930","article-title":"Risk of shingles in adults with primary Sjogren's syndrome and treatments: a nationwide population-based cohort study","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2025090312575769000_5.2.e001041.47","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.152"},{"key":"2025090312575769000_5.2.e001041.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.08.003"},{"key":"2025090312575769000_5.2.e001041.49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001138","article-title":"Increased risk of herpes zoster following dermatomyositis and polymyositis: a nationwide population-based cohort study","volume":"94","author":"Tsai","year":"2015","journal-title":"Medicine"},{"key":"2025090312575769000_5.2.e001041.50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaad.2016.02.1153","article-title":"The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (pv), and bullous pemphigoid (BP)","volume":"75","author":"Robinson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2025090312575769000_5.2.e001041.51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq200"},{"key":"2025090312575769000_5.2.e001041.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.07.009"},{"key":"2025090312575769000_5.2.e001041.53","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2025090312575769000_5.2.e001041.54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014032","article-title":"Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"2025090312575769000_5.2.e001041.55","first-page":"962","article-title":"Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review","volume":"30","author":"Zhang","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312575769000_5.2.e001041.56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210708"},{"key":"2025090312575769000_5.2.e001041.57","doi-asserted-by":"crossref","unstructured":"Tanaka Y , Ishii T , Cai Z . Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: a 52-week, randomized, single-blind, extension study. Modern rheumatology 2017:1\u201310.","DOI":"10.1080\/14397595.2017.1307899"},{"key":"2025090312575769000_5.2.e001041.58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2015.12.059","article-title":"Immunosuppressive medication use and risk of herpes zoster (Hz) in patients with systemic lupus erythematosus (SLE): a nationwide case-control study","volume":"75","author":"Hu","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2025090312575769000_5.2.e001041.59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an Anti-Interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090312575769000_5.2.e001041.60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208562"},{"key":"2025090312575769000_5.2.e001041.61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144918","article-title":"National lupus hospitalization trends reveal rising rates of herpes zoster and declines in Pneumocystis pneumonia","volume":"11","author":"Murray","year":"2016","journal-title":"PLoS One"},{"key":"2025090312575769000_5.2.e001041.62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090312575769000_5.2.e001041.63","doi-asserted-by":"publisher","DOI":"10.1086\/657321"},{"key":"2025090312575769000_5.2.e001041.64","doi-asserted-by":"publisher","DOI":"10.1002\/art.20616"},{"key":"2025090312575769000_5.2.e001041.65","doi-asserted-by":"publisher","DOI":"10.1002\/art.22667"},{"key":"2025090312575769000_5.2.e001041.66","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310372952"},{"key":"2025090312575769000_5.2.e001041.67","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090644"},{"key":"2025090312575769000_5.2.e001041.68","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2010.25.10.1431"},{"key":"2025090312575769000_5.2.e001041.69","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311425517"},{"key":"2025090312575769000_5.2.e001041.70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","article-title":"Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus","volume":"33","author":"Lyrio","year":"2013","journal-title":"Rheumatol Int"},{"key":"2025090312575769000_5.2.e001041.71","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.6061\/clinics\/2013(12)01","article-title":"The impact of glucocorticoids and anti-CD20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus","volume":"68","author":"Mendoza-Pinto","year":"2013","journal-title":"Clinics"},{"key":"2025090312575769000_5.2.e001041.72","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314559628"},{"key":"2025090312575769000_5.2.e001041.73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/751853","article-title":"Predisposition to cervical atypia in systemic lupus erythematosus: a clinical and Cytopathological study","volume":"2015","author":"Al-Sherbeni","year":"2015","journal-title":"Autoimmune Dis"},{"key":"2025090312575769000_5.2.e001041.74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/0961203316686708","article-title":"Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women","volume":"26","author":"Mendoza-Pinto","year":"2017","journal-title":"Lupus"},{"key":"2025090312575769000_5.2.e001041.75","first-page":"47","article-title":"Clinical and epidemiological study of human papillomavirus infection in women with systemic lupus erythematosus in eastern Brazilian Amazon","volume":"42","author":"Amaral","year":"2017","journal-title":"Acta Reumatol Port"},{"key":"2025090312575769000_5.2.e001041.76","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/0961203318773176","article-title":"Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus","volume":"27","author":"M\u00e9ndez-Mart\u00ednez","year":"2018","journal-title":"Lupus"},{"key":"2025090312575769000_5.2.e001041.77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00296-014-3157-1","article-title":"Human papillomavirus and Chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study","volume":"35","author":"Waisberg","year":"2015","journal-title":"Rheumatol Int"},{"issue":"Suppl 86","key":"2025090312575769000_5.2.e001041.78","first-page":"S-145","article-title":"Screening of human papillomavirus infection in women with systemic sclerosis","volume":"32","author":"Martin","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312575769000_5.2.e001041.79","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61412-X"},{"key":"2025090312575769000_5.2.e001041.80","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1188-9"},{"key":"2025090312575769000_5.2.e001041.81","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-011-0458-z"},{"key":"2025090312575769000_5.2.e001041.82","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00296-011-1934-7","article-title":"Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from South China","volume":"32","author":"Zheng","year":"2012","journal-title":"Rheumatol Int"},{"key":"2025090312575769000_5.2.e001041.83","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3923\/pjbs.2013.747.750","article-title":"Prevalence of hepatitis B infection in rheumatoid arthritis patients","volume":"16","author":"Alishiri","year":"2013","journal-title":"Pak J Biol Sci"},{"key":"2025090312575769000_5.2.e001041.84","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3109\/s10165-012-0797-4","article-title":"Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy","volume":"23","author":"Watanabe","year":"2013","journal-title":"Mod Rheumatol"},{"key":"2025090312575769000_5.2.e001041.85","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.233.129"},{"key":"2025090312575769000_5.2.e001041.86","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jvh.12302","article-title":"Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population","volume":"21","author":"Sui","year":"2014","journal-title":"J Viral Hepat"},{"key":"2025090312575769000_5.2.e001041.87","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.12659\/MSM.893691","article-title":"Hepatitis B virus infection rate and distribution in Chinese systemic lupus erythematosus patients","volume":"21","author":"Chen","year":"2015","journal-title":"Med Sci Monit"},{"key":"2025090312575769000_5.2.e001041.88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874312901610010039","article-title":"Hepatitis B serology in patients with rheumatic diseases","volume":"10","author":"Feuchtenberger","year":"2016","journal-title":"Open Rheumatol J"},{"key":"2025090312575769000_5.2.e001041.89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196210","article-title":"Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections","volume":"13","author":"Chiu","year":"2018","journal-title":"PLoS One"},{"key":"2025090312575769000_5.2.e001041.90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40471-018-0136-1","article-title":"The burden of influenza: a complex problem","volume":"5","author":"Gordon","year":"2018","journal-title":"Curr Epidemiol Rep"},{"key":"2025090312575769000_5.2.e001041.91","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22575"},{"key":"2025090312575769000_5.2.e001041.92","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311429556"},{"key":"2025090312575769000_5.2.e001041.93","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12535","article-title":"Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study","volume":"280","author":"Gr\u00f6nlund","year":"2016","journal-title":"J Intern Med"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2019-001041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:58:08Z","timestamp":1756929488000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2019-001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":93,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,9,19]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/rmdopen-2019-001041"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2019-001041","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}